Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

In recently published research in the journal Neurology, the team tracked records for 4,593 people living with multiple sclerosis from 2019 to 2020, 673 in rural areas and 3,920 in urban centers.

Get Instant Summarized Text (Gist) New therapeutic targets for multiple sclerosis (MS) tissue recovery have been identified, potentially leading to treatments that promote myelin repair. Current ...

More data are needed on its efficacy and safety in treating relapsing multiple sclerosis. In two phase 3, double-blind, double-dummy, event-driven trials (GEMINI 1 and GEMINI 2), participants with ...

Bike MS hosts its MS 150 bike ride over the weekend to bring awareness and funds towards curing Multiple Sclerosis (MS). This 150-mile bike ride is not a race, but rather a fundraiser across the ...

By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...

In older patients undergoing surgery, preoperative macular thickness may be a marker for vulnerability to developing postoperative delirium.

While topline results of HERCULES were first presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting last September, the peer-reviewed paper offers ...

slowed disability progression by 31% in patients with nonrelapsing secondary progressive multiple sclerosis (nrSPMS), results of a multi-center phase 3 study showed. “Although tolebrutinib was ...

However, finding the connection was not easy. “It started with the observation that the epidemiology of multiple sclerosis is quite unique because there is a very striking geographical ...